| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
52,690 |
41,750 |
$3.61M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,463 |
23,112 |
$1.96M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15,801 |
14,935 |
$1.20M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
8,577 |
6,268 |
$593K |
| 15780 |
|
438 |
304 |
$252K |
| 96156 |
|
2,176 |
2,128 |
$130K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,493 |
1,439 |
$117K |
| 99070 |
|
8,186 |
7,366 |
$41K |
| 99215 |
Prolong outpt/office vis |
174 |
172 |
$22K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
208 |
208 |
$20K |
| G9920 |
Screening performed and negative |
595 |
593 |
$20K |
| 93000 |
|
2,534 |
2,470 |
$19K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,209 |
3,899 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
553 |
402 |
$18K |
| 99385 |
|
231 |
215 |
$18K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,410 |
3,193 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,693 |
1,528 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
80 |
80 |
$9K |
| 90674 |
|
281 |
275 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,511 |
1,450 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,652 |
7,771 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
577 |
558 |
$5K |
| 96150 |
|
311 |
300 |
$4K |
| 96151 |
|
277 |
277 |
$3K |
| 99386 |
|
100 |
100 |
$3K |
| 99496 |
|
14 |
14 |
$3K |
| 90656 |
|
94 |
92 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15,278 |
12,818 |
$2K |
| 90686 |
|
59 |
58 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
141 |
137 |
$1K |
| G9919 |
Screening performed and positive and provision of recommendations |
32 |
32 |
$1K |
| 81002 |
|
7,672 |
7,318 |
$624.54 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
34 |
34 |
$582.76 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
167 |
158 |
$543.24 |
| 81025 |
|
3,183 |
3,094 |
$493.20 |
| 36415 |
Collection of venous blood by venipuncture |
834 |
804 |
$440.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
31 |
28 |
$430.44 |
| 69210 |
|
130 |
123 |
$402.70 |
| 97602 |
|
659 |
466 |
$276.69 |
| 99000 |
|
1,376 |
1,366 |
$222.26 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
52 |
50 |
$200.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
33 |
33 |
$199.04 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
3,150 |
2,985 |
$135.60 |
| 99354 |
|
14 |
14 |
$134.94 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
856 |
814 |
$128.95 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,845 |
1,820 |
$49.40 |
| 86769 |
|
1,103 |
1,077 |
$44.61 |
| 36416 |
|
1,039 |
1,018 |
$35.34 |
| 81000 |
|
68 |
67 |
$30.27 |
| 82962 |
|
317 |
312 |
$22.14 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,044 |
1,036 |
$13.24 |
| 69209 |
|
66 |
66 |
$11.54 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
491 |
445 |
$0.01 |
| 57410 |
|
26 |
26 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
12 |
12 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
19 |
19 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
14 |
14 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
220 |
214 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
41 |
40 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
23 |
23 |
$0.00 |